Pioneering a new approach to biological discovery

IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.

About usContact us

Our proteins power discovery

IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.

About IPI →

Woman in glasses and lab coat holding pipette.

Academic expertise

Our Harvard-based scientists collaboratively take on complex projects in the areas most in need of transformative antibodies and other proteins.

Learn about our research →

Man working in cell biology lab.

Industrial platform

We achieve unprecedented scale with a platform and technologies based on high-quality protein and antibody design, expression and production.

Learn about our Platform →

IPI in brief

Drawing Of Microscope.

Meeting research needs

IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Basic Drawing Of Antibody.

Best of both worlds

IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Figure Representing Business Model.

Unique business model

IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Drawing Of Lightbulb.

Cross-disciplinary connections

IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.

Building collaborations

IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.

Collaborate with us →

News from the lab

More IPI news →

Crowd listens to six researchers discuss antibody access and reproducibility on a small stage.

Panelists discuss antibody distribution and access at IPI Surfacing on June 15, 2023. IPI photo by Pat Piasecki.
Science news

At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility

In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein tools...

Read more
Three photos picturing Deepash Kothiwal working in the lab, Mahesh Vangala smiling in front of a computer with antibody data, and Nirakar Basnet looking at protein images.

From left: Deepash Kothiwal working in the lab; Mahesh Vangala pictured in front of the IPI Dataverse; and Nirakar Basnet doing protein research.
People

IPI broadens scientific expertise with new talent

In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who've joined IPI...

Read more
Two men talking in office building.

Ken Fasman (right) at IPI Surfacing on June 15, 2023. IPI photo by Roushu Zhang.
People

From president and CEO Ken Fasman: IPI in the midst of an exciting growth year

I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering,...

Read more
Man in suit speaks from podium with Institute for Protein Innovation banner.

Tim Springer addresses the crowd at IPI Surfacing on June 15, 2023. IPI photo by Pat Piasecki.
People

IPI starts new chapter with game-changing gift: A Q&A with Tim Springer

Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a history of scientific renown and entrepreneurial success, Institute for Protein Innovation...

Read more

Get in touch today

Contact us
Back To Top